Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women

NCT02028364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Exemestane

Sponsor

Jules Bordet Institute

Collaborators

[object Object]